Biologics target and suppress specific drivers of inflammation and work well in some patients to treat the symptoms of nasal polyposis.

Sinonasal cancer shows an 11.7% recurrence rate after a five-year disease- free period, but varies by tumor pathology.
A look at the imaging characteristics and clinical outcomes of biphenotypic sinonasal sarcoma (BSS)?
There is insufficient evidence to support the use of acupuncture in CRS.
The reboot approach significantly reduced nasal polyp recurrence for 30 months postoperatively compared to the current mucosa-sparing approach.
Multiple therapeutic options may be effective for treating mild pediatric OSA including observation, management with anti-inflammatory medications, and surgery.
HTA and the Systematic Human Error Reduction and Prediction Approach (SHERPA) are valuable tools to highlight potential errors in functional endoscopic sinus surgery (FESS).
Olfaction can be improved by sinus surgery in about every second chronic rhinosinusitis (CRS) patient.
A look at how effective systemic tranexamic acid is compared to a control in blood loss, operative time, and surgical field and incidence of postoperative emesis and thromboembolism in endoscopic sinus surgery (ESS).